These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 37686837)

  • 41. Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions.
    Jafarzadeh A; Chauhan P; Saha B; Jafarzadeh S; Nemati M
    Life Sci; 2020 Sep; 257():118102. PubMed ID: 32687918
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of Adipose Tissue and Adipokines with Development of Obesity-Induced Liver Cancer.
    Rajesh Y; Sarkar D
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671547
    [TBL] [Abstract][Full Text] [Related]  

  • 43. SARS-CoV-2 and Obesity: "CoVesity"-a Pandemic Within a Pandemic.
    Zakka K; Chidambaram S; Mansour S; Mahawar K; Salminen P; Almino R; Schauer P; Kinross J; Purkayastha S;
    Obes Surg; 2021 Apr; 31(4):1745-1754. PubMed ID: 33479921
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Obesity and colorectal cancer: role of adipokines in tumor initiation and progression.
    Riondino S; Roselli M; Palmirotta R; Della-Morte D; Ferroni P; Guadagni F
    World J Gastroenterol; 2014 May; 20(18):5177-90. PubMed ID: 24833848
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diabetes Mellitus, Energy Metabolism, and COVID-19.
    Conte C; Cipponeri E; Roden M
    Endocr Rev; 2024 Mar; 45(2):281-308. PubMed ID: 37934800
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of IL-1 family of cytokines and receptors in pathogenesis of COVID-19.
    Makaremi S; Asgarzadeh A; Kianfar H; Mohammadnia A; Asghariazar V; Safarzadeh E
    Inflamm Res; 2022 Aug; 71(7-8):923-947. PubMed ID: 35751653
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oxidative Stress as Key Player in Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection.
    Delgado-Roche L; Mesta F
    Arch Med Res; 2020 Jul; 51(5):384-387. PubMed ID: 32402576
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Review: Obesity and COVID-19: A Detrimental Intersection.
    Gammone MA; D'Orazio N
    Front Endocrinol (Lausanne); 2021; 12():652639. PubMed ID: 33995281
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vascular effects of novel adipocytokines: focus on vascular contractility and inflammatory responses.
    Yamawaki H
    Biol Pharm Bull; 2011; 34(3):307-10. PubMed ID: 21372376
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adiponectin: a key player in obesity related disorders.
    Matsuzawa Y
    Curr Pharm Des; 2010 Jun; 16(17):1896-901. PubMed ID: 20370675
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Obesity and COVID-19 : Mechanisms involved in the collusion of two pandemics].
    Favre L; Pantet O; Papadimitriou Olivgeris M
    Rev Med Suisse; 2021 Mar; 17(731):558-563. PubMed ID: 33760416
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The new adipose tissue and adipocytokines.
    Bulcão C; Ferreira SR; Giuffrida FM; Ribeiro-Filho FF
    Curr Diabetes Rev; 2006 Feb; 2(1):19-28. PubMed ID: 18220614
    [TBL] [Abstract][Full Text] [Related]  

  • 53. COVID-19 and obesity: the meeting of two pandemics.
    Brandão SCS; Godoi ETAM; de Oliveira Cordeiro LH; Bezerra CS; de Oliveira Xavier Ramos J; de Arruda GFA; Lins EM
    Arch Endocrinol Metab; 2021 Nov; 65(1):3-13. PubMed ID: 33320454
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased TLR/MyD88 signaling in patients with obesity: is there a link to COVID-19 disease severity?
    Cuevas AM; Clark JM; Potter JJ
    Int J Obes (Lond); 2021 May; 45(5):1152-1154. PubMed ID: 33637950
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inflammation and oxidative stress, the links between obesity and COVID-19: a narrative review.
    Moreno-Fernandez J; Ochoa J; Ojeda ML; Nogales F; Carreras O; Díaz-Castro J
    J Physiol Biochem; 2022 Aug; 78(3):581-591. PubMed ID: 35316507
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diabetes Mellitus and SARS-CoV-2 Infection: Pathophysiologic Mechanisms and Implications in Management.
    Vallianou NG; Evangelopoulos A; Kounatidis D; Stratigou T; Christodoulatos GS; Karampela I; Dalamaga M
    Curr Diabetes Rev; 2021; 17(6):e123120189797. PubMed ID: 33388022
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Obesity in COVID-19 era, implications for mechanisms, comorbidities, and prognosis: a review and meta-analysis.
    Aghili SMM; Ebrahimpur M; Arjmand B; Shadman Z; Pejman Sani M; Qorbani M; Larijani B; Payab M
    Int J Obes (Lond); 2021 May; 45(5):998-1016. PubMed ID: 33637951
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review.
    Quirch M; Lee J; Rehman S
    J Med Internet Res; 2020 Aug; 22(8):e20193. PubMed ID: 32707537
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immune characterization and profiles of SARS-CoV-2 infected patients reveals potential host therapeutic targets and SARS-CoV-2 oncogenesis mechanism.
    Policard M; Jain S; Rego S; Dakshanamurthy S
    Virus Res; 2021 Aug; 301():198464. PubMed ID: 34058265
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Leptin and adipocytokines: bridging the gap between immunity and atherosclerosis.
    Matarese G; Mantzoros C; La Cava A
    Curr Pharm Des; 2007; 13(36):3676-80. PubMed ID: 18220805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.